September 25 (SeeNews) - US-based pharmaceutical and life sciences specialised services company Precision Medicine Group has set foot in Serbia and Romania through the acquisition of Hungary's Argint International, Precision said on Tuesday.
The acquisition is part of Precision's global growth plan and the European footprint of the company now includes and offices in Edinburgh, Paris, Berlin, Geneva, Budapest, Bucharest, Bratislava, and Belgrade, the US-based group said in a statement.
You can subscribe to our M&A newsletter here
The transaction was carried out through Precision for Medicine, a subsidiary of Precision Medicine Group, the company said.
"The addition of the Argint team augments and enhances our European platform, which is critical due to the significant number of customers we have throughout Europe - and also the number of sites and patients seeking novel therapies derived from the benefits of precision medicine," president Chad Clark said in the statement.
Precision for Medicine supports life sciences companies in the use of biomarkers essential to targeting patients more precisely and effectively.